Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-108834
Filing Date
2025-08-14
Accepted
2025-08-14 16:02:32
Documents
58
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q eq-20250630.htm   iXBRL 10-Q 2322120
2 EX-4.5 eq-ex4_5.htm EX-4.5 246881
3 EX-31.1 eq-ex31_1.htm EX-31.1 12671
4 EX-32.1 eq-ex32_1.htm EX-32.1 8884
  Complete submission text file 0000950170-25-108834.txt   8389188

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eq-20250630.xsd EX-101.SCH 1119619
61 EXTRACTED XBRL INSTANCE DOCUMENT eq-20250630_htm.xml XML 1267906
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

EIN.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38692 | Film No.: 251218533
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)